These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 22319976

  • 1. Pegylated interferon associated lichen planus at the injection site.
    Ergül B, Koçak E, Akbal E, Köklü S, Astarci HM.
    Acta Gastroenterol Belg; 2011 Dec; 74(4):591-2. PubMed ID: 22319976
    [No Abstract] [Full Text] [Related]

  • 2. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha].
    Montero-Tinnirello J, de la Fuente-Aguado J, Rodríguez-Pecci MS, Fernández-Fernández FJ.
    Rev Clin Esp; 2011 Sep; 211(8):436-8. PubMed ID: 21546017
    [No Abstract] [Full Text] [Related]

  • 3. Erythema gyratum repens induced by pegylated interferon alfa for chronic hepatitis C.
    Rongioletti F, Fausti V, Parodi A.
    Arch Dermatol; 2012 Oct; 148(10):1213-4. PubMed ID: 23069974
    [No Abstract] [Full Text] [Related]

  • 4. Reversible sudden sensorineural hearing loss during chronic hepatitis C treatment with pegylated interferon/ribavirin.
    Papastergiou V, Skorda L, Lisgos P, Karatapanis S.
    Acta Gastroenterol Belg; 2011 Dec; 74(4):582-4. PubMed ID: 22319972
    [No Abstract] [Full Text] [Related]

  • 5. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
    Hu CC, Chien RN.
    Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679
    [No Abstract] [Full Text] [Related]

  • 6. Choreiform movements associated with pegylated interferon-alpha in a patient with chronic hepatitis C.
    Akin M, İşler M, Şenol A, Kutluhan S, Tüfekçı A.
    Turk J Gastroenterol; 2012 Feb; 23(5):618-9. PubMed ID: 23161317
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ, Romagosa R, Vincek V.
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
    Quinn D, Kuchler E, Deming P, Arora S.
    Psychosomatics; 2012 Apr; 53(4):400-1. PubMed ID: 22748752
    [No Abstract] [Full Text] [Related]

  • 15. Peripheral nervous system involvement in a haemodialysis patient treated with pegylated interferon.
    Ruiz-Fuentes MC, Rubert-Gómez De Quero A, De Gracia-Guindo C, Galindo-Sacristán P, Osuna-Ortega A.
    Nefrologia; 2012 Apr; 32(6):863-5. PubMed ID: 23169385
    [No Abstract] [Full Text] [Related]

  • 16. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
    Burgueño-Montañés C, Pérez-Álvarez R.
    Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].
    Bruch-Gerharz D, Reifenberger J.
    Hautarzt; 2006 Apr; 57(4):317-35. PubMed ID: 16523277
    [No Abstract] [Full Text] [Related]

  • 19. [Tuberculous lymphadenitis after successful treatment of hepatitis C].
    Velasco J, González S.
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):631. PubMed ID: 21570741
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.